A Phase 1b, Open-Label Study of the Safety, Pharmacokinetics, and Pharmacodynamics of JNJ-64264681 in Combination with JNJ-67856633 in Participants with Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia

Project: Research

Project Details

StatusActive
Effective start/end date24/06/2123/06/26

Keywords

  • phase 1 study
  • leukemia
  • Non-Hodgkin's Lymphoma